GO:0036002 pre-mRNA binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036002 (pre-mRNA binding) is a molecular function describing binding to pre-messenger RNA, the primary transcript that still contains introns and is later processed into mRNA.
• Pre-mRNA binding proteins recognize sequence elements, secondary structures and chemical marks on nascent transcripts to control splicing, 3' end formation and transcript fate.
• The nuclear cap-binding complex (CBC) is a central pre-mRNA binding hub that couples transcription with capping, splicing and polyadenylation.
• Pre-mRNA binding by factors such as HP1gamma and hnRNP C can directly change splicing decisions or protect the transcriptome from circularization.
• Pseudouridine synthases bind and modify pre-mRNA co-transcriptionally, showing that RNA modification and pre-mRNA binding are functionally linked.
• Deregulated pre-mRNA binding and splicing are associated with human disease, and antisense oligonucleotides can therapeutically modulate pre-mRNA splicing.
Description
GO:0036002, pre-mRNA binding, is a molecular function term in the Gene Ontology that describes the selective interaction of a protein or ribonucleoprotein with pre-messenger RNA, the primary transcript produced by RNA polymerase II before intron removal and 3' end maturation. Pre-mRNA is an intermediate molecule between DNA and protein that may contain introns and, at least in part, encodes one or more proteins; introns are removed from pre-mRNA to form mRNA. Because nearly all human protein-coding genes produce pre-mRNA that must be spliced, capped, edited and polyadenylated, proteins that bind pre-mRNA are central to gene expression. Researchers study pre-mRNA binding to understand how sequence elements, RNA structure and RNA modifications are decoded into precise splicing and processing decisions. The function is experimentally defined by biochemical and cellular assays showing direct or complex-mediated association with pre-mRNA, often coupled to effects on splicing, polyadenylation or transcript stability. This article summarizes the mechanism, key genes, disease links and research methods for GO:0036002, based on published literature.
pre-mRNA binding At A Glance
| GO ID | GO:0036002 |
|---|---|
| GO term | pre-mRNA binding |
| Ontology | molecular_function |
| Synonym | protein-coding primary transcript binding |
| Definition | Binding to a pre-messenger RNA (pre-mRNA), an intermediate molecule between DNA and protein that may contain introns and, at least in part, encodes one or more proteins. Introns are removed from pre-mRNA to form a mRNA molecule. |
| Major function | Recognition of intron-containing primary transcripts to enable splicing, capping, polyadenylation and transcript fate decisions. |
| Representative binders | Nuclear cap-binding complex, hnRNP proteins, HP1gamma, pseudouridine synthases, polyadenylation factors. |
| Coupled processes | Splicing, alternative splicing, 3' end formation, RNA modification, circular RNA biogenesis. |
| Disease relevance | Splice-site mutations and deregulated RNA binding contribute to genetic disease and cancer. |
What Is GO:0036002?
In our own words, pre-mRNA binding (GO:0036002) is the molecular function of physically associating with pre-messenger RNA, the intron-containing primary transcript generated from a protein-coding gene. This binding can occur co-transcriptionally or post-transcriptionally and may involve sequence-specific recognition, structure-specific recognition or recognition of chemical marks on the RNA. Pre-mRNA binding is a prerequisite for many processing events, including splice site selection, exon definition, 3' end cleavage and polyadenylation, and quality control of aberrant transcripts. The term is a molecular function, not a biological process or cellular component, and it is distinct from mature mRNA binding or general single-stranded RNA binding.
Why Is pre-mRNA binding Important in Cell Biology?
Pre-mRNA binding is important because it is the first committed step that determines how a primary transcript is interpreted by the cell. Proteins that bind pre-mRNA read sequence elements, structures and modifications to select splice sites, define exons, recruit the spliceosome and couple splicing with transcription and 3' end formation. Because most human genes undergo alternative splicing, pre-mRNA binding events directly expand proteome diversity and influence cell fate, differentiation and stress responses. Defects in pre-mRNA binding or in the RNA elements they recognize cause or modify human disease, including inherited splicing disorders and cancer, and are actionable targets for antisense oligonucleotide therapeutics. Studying GO:0036002 therefore connects molecular recognition to physiology, disease mechanism and RNA-based therapy.
• Pre-mRNA binding initiates splice site recognition and exon definition, which are required for accurate mRNA production.
• It couples transcription with capping, splicing and polyadenylation through factors such as the nuclear cap-binding complex.
• It enables alternative splicing, a major source of proteome diversity in human cells.
• It allows co-transcriptional RNA modification, as shown for pseudouridine synthases acting on pre-mRNA.
• It controls transcript fate, including protection from circularization by hnRNP C binding to inverted Alu elements.
• It contributes to 3' end formation through polyadenylation complex recognition of downstream cis-elements.
• Disease-causing sequence changes often act by altering pre-mRNA binding and splicing decisions.
• Antisense oligonucleotides can modulate pre-mRNA splicing by blocking or redirecting RNA-binding events.
• Pre-mRNA structures themselves can determine whether transcripts form circular RNAs, linking binding to noncoding RNA biogenesis.
• Pre-mRNA binding factors are candidate therapeutic targets and biomarkers in cancer and genetic disease.
What Happens During pre-mRNA binding?
Co-transcriptional recognition of nascent pre-mRNA
In simple terms: As the gene is being copied into RNA, proteins grab the new RNA and start deciding what to do with it.
Pre-mRNA binding begins co-transcriptionally, when RNA-binding proteins and complexes associate with the nascent transcript emerging from RNA polymerase II. The nuclear cap-binding complex binds the 5' cap and acts as a choreographer of gene transcription and pre-mRNA processing, linking capping to downstream splicing and polyadenylation events. Pseudouridine synthases modify human pre-mRNA co-transcriptionally and affect pre-mRNA processing, demonstrating that binding and chemical modification of nascent transcripts are coupled. This early recognition helps set up the transcript for correct processing before it is released from chromatin.
Splice site selection and exon definition
In simple terms: Binding proteins mark which parts of the RNA should be kept and which should be cut out.
Once bound, pre-mRNA-binding factors help the spliceosome identify authentic splice sites and define exons. Sequence changes that alter these recognition events are a common cause of disease because they change splicing outcomes. HP1gamma binding to pre-mRNA intronic repeats modulates RNA splicing decisions, showing that chromatin-associated proteins can also act directly on pre-mRNA to influence splice site choice. This step determines the final exon composition of the mRNA and therefore the protein product.
Regulation of 3' end formation and polyadenylation
In simple terms: Binding proteins also tell the RNA where to end and add a tail.
Pre-mRNA binding is required for 3' end cleavage and polyadenylation. In Arabidopsis, the polyadenylation complex CFII recognizes a downstream cis-element for pre-mRNA polyadenylation through interaction with an RNA-binding protein, illustrating that pre-mRNA binding directly guides polyadenylation site choice. In human cells, coupling between cap-binding, splicing and 3' end formation ensures that only properly processed transcripts are exported and translated. Defects in these recognition events can produce aberrant transcripts with altered stability or coding potential.
Transcript fate decisions and circular RNA control
In simple terms: Binding proteins can also protect RNA or send it down alternative pathways.
Pre-mRNA binding influences whether a transcript follows the canonical linear mRNA pathway or alternative fates such as circular RNA formation. Pre-mRNA structures forming circular RNAs are shaped by intronic repeats and competing base-pairing, and hnRNP C binding to inverted Alu elements protects the transcriptome from pre-mRNA circularization. This shows that pre-mRNA binding acts as a gatekeeper that suppresses or permits noncanonical processing. These decisions affect the abundance of both linear mRNAs and circular RNAs in cells.
Key Genes Involved in GO:0036002 pre-mRNA binding
The following genes and proteins represent major pre-mRNA-binding factors and processing components discussed in the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NCBP1 | Core subunit of the nuclear cap-binding complex that binds the 5' cap of pre-mRNA | Central to coupling transcription with pre-mRNA processing |
| NCBP2 | Cap-binding complex subunit that recognizes the pre-mRNA 5' cap | Model for cap-dependent pre-mRNA binding and processing |
| HNRNPC | Binds inverted Alu elements in pre-mRNA | Protects transcriptome from pre-mRNA circularization |
| CBX3 (HP1gamma) | Binds pre-mRNA intronic repeats | Modulates RNA splicing decisions |
| PUS1 | Pseudouridine synthase acting on pre-mRNA | Links co-transcriptional modification to pre-mRNA processing |
| PUS7 | Pseudouridine synthase acting on pre-mRNA | Links co-transcriptional modification to pre-mRNA processing |
| CPSF subunits | Recognize polyadenylation signals in pre-mRNA | Required for 3' end formation |
| CstF subunits | Bind downstream elements for cleavage and polyadenylation | Required for 3' end formation |
| CFII subunits | Recognize downstream cis-elements with RNA-binding proteins | Pre-mRNA polyadenylation in plants |
| SRSF proteins | Sequence-specific splicing enhancer binding | Splice site selection and disease mechanisms |
| hnRNP A/B proteins | Splicing silencer and exon definition roles | Alternative splicing regulation |
| U1 snRNP components | Recognize 5' splice sites on pre-mRNA | Early spliceosome assembly |
| U2AF subunits | Bind 3' splice site region | Splice site selection |
| SF1 | Binds branch point sequence | Spliceosome assembly |
| PTBP1 | Polypyrimidine tract binding protein | Alternative splicing regulation |
| RBM proteins | Modulate splicing and processing | Disease-associated splicing factors |
How Is pre-mRNA binding Regulated?
Pre-mRNA binding is regulated at multiple levels. The nuclear cap-binding complex coordinates transcription and pre-mRNA processing, so changes in transcription elongation or chromatin state can alter which factors engage the nascent transcript. Co-transcriptional RNA modification by pseudouridine synthases can change pre-mRNA structure and protein binding, thereby influencing processing outcomes. Competition between RNA-binding proteins for overlapping or structured elements, such as hnRNP C binding to inverted Alu elements, determines whether a transcript is protected from circularization. In addition, the availability of processing complexes such as CFII and their interaction with RNA-binding proteins controls polyadenylation site recognition. These layers of regulation allow cells to tune splicing and processing in response to developmental and environmental signals.
pre-mRNA binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HNRNPC | Transcriptome stability and circular RNA control | KO and RNA-seq in human cell lines |
| CBX3 (HP1gamma) | Splicing decisions and chromatin-RNA coupling | Point mutation and minigene splicing assays |
| PUS1 / PUS7 | Co-transcriptional pre-mRNA modification and processing | KO and modification mapping |
| CPSF / CstF subunits | 3' end formation defects | Knock-in of polyadenylation signal variants |
| SRSF / hnRNP family | Splicing disorders and cancer | Overexpression and KO models with RNA-seq |
Splicing disorders caused by altered pre-mRNA recognition
Disease-causing sequence changes frequently act by disrupting pre-mRNA binding and splice site recognition, leading to aberrant splicing. Assessing these changes requires functional splicing assays because the effect depends on the sequence context and the RNA-binding factors present. Antisense oligonucleotides can be used to modulate pre-mRNA splicing and correct or bypass such defects, illustrating the therapeutic relevance of pre-mRNA binding.
Cancer and deregulated RNA processing
Altered expression or activity of pre-mRNA-binding proteins can change splicing programs in cancer cells, contributing to proliferation and survival phenotypes. Because pre-mRNA binding controls exon inclusion and 3' end formation, its deregulation can produce oncogenic or tumor-suppressive isoforms. Targeting splicing and pre-mRNA recognition is therefore an active area of cancer research.
Noncoding RNA biogenesis and transcriptome stability
Pre-mRNA binding also affects the balance between linear and circular RNA production. hnRNP C binding to inverted Alu elements protects the transcriptome from pre-mRNA circularization, and loss of this protection can alter circular RNA levels. Pre-mRNA structures that form circular RNAs are themselves shaped by intronic repeats, linking RNA structure and binding to noncoding RNA output. These mechanisms are relevant to diseases where circular RNA or transcript stability is perturbed.
From pre-mRNA binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate pre-mRNA-binding protein required for splicing of a target transcript? | CRISPR knockout followed by RNA-seq and RT-PCR |
| Does a disease-associated variant change pre-mRNA binding or splicing? | Point-mutation knock-in and minigene assays |
| Where does a pre-mRNA-binding protein localize and when does it bind? | Tagged knock-in with imaging and RNA immunoprecipitation |
| Does overexpression of a splicing factor change isoform ratios? | Overexpression cell model with RNA-seq |
| Does loss of protection cause circular RNA accumulation? | KO of hnRNP C and circular RNA sequencing |
| Does a modification enzyme act on pre-mRNA co-transcriptionally? | KO of pseudouridine synthase and modification mapping |
How to Study the pre-mRNA binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA immunoprecipitation | Physical association of a protein with pre-mRNA | Mapping pre-mRNA binding sites |
| CLIP / crosslinking | Direct RNA-protein contacts | Defining binding motifs and structures |
| Minigene splicing assay | Exon inclusion or skipping | Testing disease variants |
| RNA-seq | Transcriptome-wide isoform changes | KO or overexpression effects |
| Pseudouridine mapping | Pre-mRNA modification sites | Linking modification to processing |
| RNA structure probing | Folding of intronic regions | Circular RNA formation studies |
| Polyadenylation assay | 3' end cleavage and polyadenylation site usage | Testing CFII and RNA-binding protein function |
| Antisense oligonucleotide treatment | Splicing modulation | Therapeutic splicing correction |
RNA immunoprecipitation and CLIP-based mapping
RNA immunoprecipitation and crosslinking-based methods identify which pre-mRNA regions are bound by a protein of interest. These approaches are used to map binding of factors such as hnRNP C to inverted Alu elements and to define intronic repeat binding by HP1gamma. When combined with sequencing, they reveal binding motifs and structural preferences.
Splicing assays and minigenes
Minigene and endogenous splicing assays measure how sequence variants or factor depletion change exon inclusion. They are essential for assessing disease-causing sequence changes that affect pre-mRNA binding and splice site selection. Antisense oligonucleotide experiments can be added to test whether splicing can be redirected.
RNA modification and structure mapping
Modification mapping detects marks such as pseudouridine on pre-mRNA and links them to processing changes. RNA structure probing identifies intronic repeats and base-pairing that influence circular RNA formation and protein binding. Together these methods connect pre-mRNA binding to RNA chemistry and folding.
3' end and polyadenylation assays
Polyadenylation assays measure cleavage and polyadenylation site usage in response to changes in RNA-binding proteins or cis-elements. They have been used to show that the CFII complex recognizes downstream cis-elements through interaction with an RNA-binding protein. These assays complement splicing readouts to give a full picture of pre-mRNA processing.
How CRISPR Can Be Used to Study GO:0036002 pre-mRNA binding
Knockout
CRISPR knockout of genes encoding pre-mRNA-binding proteins is used to test whether they are required for specific splicing or processing events. For example, knocking out hnRNP C can reveal its role in protecting transcripts from circularization, and knocking out pseudouridine synthases can reveal effects on pre-mRNA processing. Knockout cell models are typically analyzed by RNA-seq and targeted splicing assays.
Point Mutation
Point-mutation knock-in allows researchers to test whether a specific residue or RNA element is required for pre-mRNA binding. This is valuable for modeling disease-associated sequence changes that alter splice site recognition. Point mutants can also be used to separate binding from downstream processing functions.
Knock-in
Tagged knock-in of pre-mRNA-binding factors enables localization and interaction studies in a native context. Knock-in of reporter minigenes containing disease variants allows splicing outcomes to be measured in cells. These models are useful for linking binding events to processing decisions.
Overexpression
Overexpression of splicing factors or RNA-binding proteins can shift isoform ratios and reveal dominant effects on pre-mRNA processing. Overexpression models are often combined with RNA-seq to identify transcriptome-wide changes. They complement loss-of-function models to establish causality.
How EDITGENE Supports pre-mRNA binding Research
Researchers studying pre-mRNA binding-related genes often need to determine whether a candidate gene is causally involved in a specific splicing or processing phenotype. Establishing causality requires clean genetic models that separate binding function from downstream effects, and that can be compared across loss-of-function, variant and overexpression contexts. EDITGENE provides the CRISPR cell models and screening services needed to build such evidence.
Contact EDITGENE today to design your custom CRISPR model for pre-mRNA binding research.
Frequently Asked Questions About pre-mRNA binding
What is GO:0036002 pre-mRNA binding?
GO:0036002 is a Gene Ontology molecular function term describing binding to pre-messenger RNA, the intron-containing primary transcript that is processed into mRNA.
What genes are involved in pre-mRNA binding?
Genes include NCBP1 and NCBP2 of the cap-binding complex, HNRNPC, CBX3 (HP1gamma), pseudouridine synthases such as PUS1 and PUS7, and polyadenylation factors such as CPSF and CstF subunits.
Why is pre-mRNA binding important for splicing?
Pre-mRNA binding proteins recognize splice sites and exons, helping the spliceosome choose correct splice junctions and produce the right mRNA isoform.
How does the nuclear cap-binding complex relate to pre-mRNA binding?
The nuclear cap-binding complex binds the 5' cap of pre-mRNA and coordinates transcription with capping, splicing and polyadenylation.
Can pre-mRNA binding affect circular RNA formation?
Yes. hnRNP C binding to inverted Alu elements protects the transcriptome from pre-mRNA circularization, and pre-mRNA structures themselves can promote circular RNA formation.
What diseases are linked to defects in pre-mRNA binding?
Disease-causing sequence changes that alter pre-mRNA binding and splicing contribute to genetic disorders, and deregulated RNA processing is observed in cancer.
How do researchers study pre-mRNA binding?
Common methods include RNA immunoprecipitation, CLIP, minigene splicing assays, RNA-seq, modification mapping and polyadenylation assays.
Can antisense oligonucleotides modulate pre-mRNA splicing?
Yes. Antisense oligonucleotides can block or redirect pre-mRNA binding events to modulate splicing, and protocols for this are well established.
Are pseudouridine synthases pre-mRNA binding proteins?
Pseudouridine synthases modify human pre-mRNA co-transcriptionally and affect pre-mRNA processing, linking them functionally to pre-mRNA binding.
What CRISPR models are useful for pre-mRNA binding research?
Knockout, point-mutation, knock-in and overexpression models are all useful, and can be combined with RNA-seq or reporter assays to test causality.
Conclusion
GO:0036002 pre-mRNA binding defines a central molecular function that connects transcription to RNA processing. Proteins that bind pre-mRNA read sequence, structure and modification information to control splicing, 3' end formation and transcript fate, and their deregulation contributes to human disease. Studying this function requires integrated genetic, biochemical and computational approaches, and CRISPR cell models provide a rigorous way to test causality. As RNA-targeted therapeutics advance, pre-mRNA binding will remain a key area of research and drug development.
References
- 1. Baralle D et al.. 2005. Splicing in action: assessing disease causing sequence changes.. J Med Genet 42(10):737-48 PMID: 16199547
- 2. Martinez NM et al.. 2022. Pseudouridine synthases modify human pre-mRNA co-transcriptionally and affect pre-mRNA processing.. Mol Cell 82(3):645-659.e9 PMID: 35051350
- 3. Rambout X et al.. 2020. The nuclear cap-binding complex as choreographer of gene transcription and pre-mRNA processing.. Genes Dev 34(17-18):1113-1127 PMID: 32873578
- 4. Welden JR et al.. 2019. Pre-mRNA structures forming circular RNAs.. Biochim Biophys Acta Gene Regul Mech 1862(11-12):194410 PMID: 31421281
- 5. Singh NN et al.. 2025. Pre-mRNA Splicing Modulation by Antisense Oligonucleotides.. Methods Mol Biol 2964:381-404 PMID: 40720032
- 6. Rachez C et al.. 2021. HP1γ binding pre-mRNA intronic repeats modulates RNA splicing decisions.. EMBO Rep 22(9):e52320 PMID: 34312949
- 7. Marini A et al.. 2026. HnRNP C binding to inverted Alu elements protects the transcriptome from pre-mRNA circularization.. Sci Adv 12(18):eaea2351 PMID: 42066070
- 8. Cao Y et al.. 2025. Polyadenylation Complex CFII Recognizes Downstream Cis-element for Pre-mRNA Polyadenylation Through Interaction with an RNA-Binding Protein in Arabidopsis.. Adv Sci (Weinh) 12(41):e04562 PMID: 40789077
